Literature DB >> 24232510

Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.

Sima Blank, Qin Wang, M Isabel Fiel, Wei Luan, Ki Won Kim, Hena Kadri, John Mandeli, Spiros P Hiotis.   

Abstract

BACKGROUND: Hepatitis B (HBV)-associated hepatocellular carcinoma (HCC) is often associated with alpha-fetoprotein (AFP) production. Although serum AFP has been demonstrated to be a prognostic factor for patient survival, optimal cutoff levels remain unclear.
METHODS: Patients with HBV-associated HCC treated by primary liver resection were prospectively followed at a single institution between 1995 and 2008. AFP level was categorized into quintiles for Kaplan–Meier analysis and multivariable Cox proportional hazards regression models.
RESULTS: Best 5-year survival after surgery was observed for patients with AFP in the first quintile (1.4-4.1 ng/mL), with progressively worse outcomes for patients in each increasing quintile. AFP was associated with overall survival (HR = 1.61; 95 % CI 1.30-1.98), disease-free survival (HR = 1.26; 95 % CI 1.10-1.44), and 2-year recurrence (HR = 1.30; 95 % CI 1.07-1.57) in multivariate analysis. Noncirrhotic patients (Ishak 1-5) with AFP in quintile 1 had 94 % 5-year survival, compared with 0 % survival for patients with AFP in quintile 5 (2,332.7-327,560.0 ng/mL) and Ishak stage 6 cirrhosis.
CONCLUSIONS: Preoperative serum AFP is an independent predictor of prognosis among HBV-HCC patients following surgical resection. Categorizing AFP into quintiles creates the opportunity to observe differences in outcomes even at low serum levels within the normal range. Additionally, combining AFP quintiles and fibrosis staging provides a predictive model of prognosis for HCC. Thus, even small differences in AFP within the normal range may impact prognosis and disease progression for HBV-HCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24232510     DOI: 10.1245/s10434-013-3357-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  23 in total

1.  HCC with low- and normal-serum alpha-fetoprotein levels.

Authors:  Brian I Carr; Hikmet Akkiz; Oguz Üsküdar; Kendal Yalçın; Vito Guerra; Sedef Kuran; Ümit Karaoğullarından; Engin Altıntaş; Ayşegül Özakyol; Salih Tokmak; Tuğsan Ballı; Mehmet Yücesoy; Halil İbrahim Bahçeci; Abdulalh Ülkü; Tolga Akçam; Kamil Yalçın Polat; Nazım Ekinci; Halis Şimşek; Necati Örmeci; Abdulalh Sonsuz; Mehmet Demir; Murat Kılıç; Ahmet Uygun; Ali Demir; Anıl Delik; Burcu Arslan; Figen Doran; Sezai Yilmaz; Yaman Tokat
Journal:  Clin Pract (Lond)       Date:  2018

Review 2.  Overexpression of ANXA2 predicts adverse outcomes of patients with malignant tumors: a systematic review and meta-analysis.

Authors:  Xinyu Liu; Ding Ma; Xiaoqian Jing; Bingrui Wang; Weiping Yang; Weihua Qiu
Journal:  Med Oncol       Date:  2014-12-05       Impact factor: 3.064

3.  Preoperative alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC): is this 50-year biomarker still up-to-date?

Authors:  Fabrice Muscari; Charlotte Maulat
Journal:  Transl Gastroenterol Hepatol       Date:  2020-10-05

4.  Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada.

Authors:  Carla S Coffin; Scott K Fung; Fernando Alvarez; Curtis L Cooper; Karen E Doucette; Claire Fournier; Erin Kelly; Hin Hin Ko; Mang M Ma; Steven R Martin; Carla Osiowy; Alnoor Ramji; Edward Tam; Jean Pierre Villeneuve
Journal:  Can Liver J       Date:  2018-12-25

5.  Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken.

Authors:  Vaneet Jearth; Prachi S Patil; Shaesta Mehta; Sridhar Sundaram; Vishal Seth; Mahesh Goel; Shraddha Patkar; Munita Bal; Vidya Rao
Journal:  J Clin Exp Hepatol       Date:  2021-11-16

6.  Living donor liver transplantation or hepatic resection combined with intraoperative radiofrequency ablation for Child-Pugh A hepatocellular carcinoma patient with Multifocal Tumours Meeting the University of California San Francisco (UCSF) criteria.

Authors:  Xi Xu; Xingyu Pu; Li Jiang; Yang Huang; Lunan Yan; Jiayin Yang; Tianfu Wen; Bo Li; Hong Wu; Wentao Wang
Journal:  J Cancer Res Clin Oncol       Date:  2020-08-27       Impact factor: 4.553

7.  Post-surgical resection prognostic value of combined OPN, MMP7, and PSG9 plasma biomarkers in hepatocellular carcinoma.

Authors:  Weiqi Rong; Yang Zhang; Lei Yang; Lin Feng; Baojun Wei; Fan Wu; Liming Wang; Yanning Gao; Shujun Cheng; Jianxiong Wu; Ting Xiao
Journal:  Front Med       Date:  2018-05-16       Impact factor: 4.592

8.  Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong.

Authors:  Miu Yee Chan; Wong Hoi She; Wing Chiu Dai; Simon Hing Yin Tsang; Kenneth Siu Ho Chok; Albert Chi Yan Chan; Jame Fung; Chung Mau Lo; Tan To Cheung
Journal:  Transl Gastroenterol Hepatol       Date:  2019-07-11

9.  Interleukin-6 as a biomarker in patients with hepatobiliary cancers.

Authors:  Rohit Gosain; Sidra Anwar; Austin Miller; Renuka Iyer; Sarbajit Mukherjee
Journal:  J Gastrointest Oncol       Date:  2019-06

10.  High level of serum protein DKK1 predicts poor prognosis for patients with hepatocellular carcinoma after hepatectomy.

Authors:  Qiujin Shen; Xin-Rong Yang; Yexiong Tan; Haiyan You; Yang Xu; Wei Chu; Tianxiang Ge; Jian Zhou; Shuang-Jian Qiu; Ying-Hong Shi; Zhigang Zhang; Jianren Gu; Hongyang Wang; Jia Fan; Wenxin Qin
Journal:  Hepat Oncol       Date:  2015-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.